Category icon
The Role of Landiolol in Clinical Practice

Gheorghe-Andrei Dan, Karol Hajnovič, Vasiliki Psallida

Category icon
P2Y12 Inhibitors for Special Populations in the Asia-Pacific Region

Jack Wei Chieh Tan, Derek P Chew, Kin Lam Tsui, et al

Category icon
Colchicine in Patients with Coronary Artery Disease

Francesco Condello, Matteo Sturla, Bernhard Reimers, et al

Category icon
Non-culprit Lesion PCI in STEMI Patients

Luigi Di Serafino, Fabio Magliulo, Giovanni Esposito,

Category icon
Patient Radiation Exposure During Primary Percutaneous Coronary…

Emily Mae L Yap, Christopher A Macaraeg, Richard Ayuson, et al

Category icon
Door-to-balloon Time in the COVID-19 Era

Haytham Mously, Nischay Shah, Zachary Zuzek, et al

Category icon
Myocardial Infarction With Non-obstructive Coronary Arteries

Sivabaskari Pasupathy, Rosanna Tavella, Simon McRae, et al

Category icon
Nitrates as a Treatment of Acute Heart Failure

Mohammad S Alzahri, Anita Rohra , W Frank Peacock,

Category icon
Management of Refractory Angina Pectoris

Kevin Cheng, Paul Sainsbury, Michael Fisher, et al

Category icon
What an Interventionalist Needs to Know About MINOCA

Robert Sykes, Daniel Doherty, Kenneth Mangion, et al

Category icon
Early Stent Thrombosis after Percutaneous Coronary Intervention for Acute…

Georgios J Vlachojannis, Bimmer E Claessen, George D Dangas,

Category icon
Intravascular Ultrasound Versus Optical Coherence Tomography for Coronary…

Krishnaraj S Rathod, Stephen M Hamshere, Daniel A Jones, et al

Category icon
Ventricular Arrhythmia after Acute MI

Justine Bhar-Amato, William Davies, Sharad Agarwal,

About

Acute coronary syndrome (ACS) is one of the most common health problems globally and a leading cause of death and signficiant morbidity in developed countries. It represents a clinical condition characterised by rapidly developing critical myocardial ischaemia. ACS encompasses three related but distinct clinical entities – unstable angina, non-ST-segment elevation MI (NSTEMI), and ST-segment elevation MI (STEMI).

Acute coronary syndromes are characterised by vascular inflammation, subsequent endothelial dysfunction and platelet activation, followed by thrombus formation. Uncontrolled thrombosis can culminate in complete vascular occlusion and STEMI.

Key diagnostic procedures for detection of patients with ACS are ECG at rest and markers of myocardial necrosis. Optical coherence tomography can be used to assess patients with ACS and is useful because it can detect plaques at high risk of rupture and provide additional information about plaque composition, thrombi and collagen. Troponin T and troponin I are specific cardiac markers for myocardial injury and diagnosing the myocardial necrosis.

Management of ACS should encompass both acute and long-term strategies.

What is Myocardial Infarction?

Also known as a heart attack, myocardial infarction (MI) is a necrosis of the heart muscle that originates from an acute obstruction of a coronary artery. It decreases blood flow and leads to irreversible damage to the heart due to myocardial ischaemia.

Related Articles

Articles

Extracorporeal Life Support for Cardiac Arrest and Cardiogenic Shock

Andrea Elliott, Garima Dahyia, Rajat Kalra,

Published:

Citation: US Cardiology Review 2021;15:e23.

P2Y12 Inhibitors for Special Populations in the Asia-Pacific Region

Jack Wei Chieh Tan, Derek P Chew, Kin Lam Tsui,

Published:

Citation: European Cardiology Review 2021;16:e43.

Colchicine in Patients with Coronary Artery Disease

Francesco Condello, Matteo Sturla, Bernhard Reimers,

Published:

Citation: European Cardiology Review 2021;16:e39.

CV Risk Biomarkers in Women with Prior Preeclampsia/HELLP Syndrome

Esmee ME Bovee, Martha Gulati, Angela Maas,

Published:

Citation: European Cardiology Review 2021;16:e36.